Together with the partnership ‘Fostering a European Research Area for Health Research’ (ERA4Health), KCE Trials is happy to announce the “Trials4Health 2026” call will open on 6 November 2025.
This call provides funding for multi-country, comparative effectiveness or drug repurposing Investigator-Initiated Clinical Studies (IICS) in Cardiovascular, Autoimmune and Metabolic diseases. Deadline for submission will be 27 January 2026.